Skip to content

A Real-world study of short- term changes in left ventricular function, functional status and Quality of life in patients with heart failure attending OPD clinic of a hospital

A Real-world study of short- term changes in left ventricular function, functional status and Quality of life in patients with heart failure attending out-patient clinic of a tertiary care hospital

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/03/041015
Enrollment
50
Registered
2022-03-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I501- Left ventricular failure, unspecified

Interventions

None listed

Sponsors

Mohd Sultan
Lead Sponsor
Dr Nidhi
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Above 18 years age,Both male and female will be included,Inclusion criteria will be a confirmed HF Patient who agrees to give informed consent

Exclusion criteria

Exclusion criteria: Pregnant or planning to be pregnant.Having any severe psychiatric or cognitive problems,Patient incompetent for interview,Patients with other comorbidities like arthritis, cancer, HIV etc,Patients who will not give informed consent,History of severe liver disease � History of severe kidney disease

Design outcomes

Primary

MeasureTime frame
To assess changes in the clinical status of heart failure patients during treatmentTimepoint: When patient first visit to the clinic it will be first time point and second will be after 3 months when patient visit to clinic

Secondary

MeasureTime frame
1. To record demographic characteristics of HF patients 2. To record changes in biochemical parameters during HF treatment 3. To assess impact of standard of therapy on left ventricular function by echocardiographic parameters 4. To assess impact of standard of therapy on QoL of HF patients using short form health survey-36(SF-36) scale 5. To assess the prevalence of cachexia in HF patients Timepoint: When patient first visit to the clinic it will be first time point and second will be after 3 months when patient visit to clinic

Countries

India

Contacts

Public ContactMohd Sultan

Jamia Hamdard

nidhiagarwal@jamiahamdard.ac.in9818334770

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026